PARP1 inhibition in naïve mouse embryonic stem cells induces viral mimicry
Nucleic Acids Research · 20.05.2026 · 54 (10)
DOI: 10.1093/nar/gkag537 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 03.06.2026. Verfasst von Jianming Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, University of Basel, Mattenstrasse 28, 4058 Basel, Switzerland. Hauptthemen laut MEDLINE: Mouse Embryonic Stem Cells, Poly (ADP-Ribose) Polymerase-1, Poly(ADP-ribose) Polymerase Inhibitors, Endogenous Retroviruses. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Network of Advanced Proteomics Infrastructure, Research Council of Norway, Mäxi-Foundation.
Abstract (Originalsprache)
PARP1/2 inhibitors (PARPi) are effective in cancer therapy due to their synthetic lethality in cells with defects in DNA double-strand break repair (DSBR). Here, we show that DSBR-proficient, naïve pluripotent mouse embryonic stem cells (mESC) exhibit high sensitivity towards PARP1/2 inhibition by talazoparib and olaparib. This sensitivity results from a two-tiered response of mESC to PARPi, starting with the activation of DNA stress signalling via ATM and followed by a p53-controlled, TET-TDG-dependent transcriptional response, including the de-repression of endogenous retroviral elements (ERVs). The resulting accumulation of double-stranded RNAs then elicits hallmarks of viral mimicry, marked by induction of type I interferon and necroptosis responses, alongside caspase activation. Accordingly, depletion of p53, TET, or TDG confers PARPi resistance in mESC. These findings highlight active DNA demethylation as a critical mediator of PARPi sensitivity in mESC and provide mechanistic insight into how DNA stress drives ERV expression in cells with accessible chromatin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedicine, University of Basel, Mattenstrasse 28, 4058 Basel, Switzerland.
- Department of Molecular Mechanisms of Disease, University of Zürich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
- Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland.
- Proteomics and Modomics Experimental Core Facility (PROMEC), Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU) and St. Olavs Hospital Central Staff, Trondheim 7491, Nor…
- RNA Mass Spectrometry Platform, Department of Chemistry, Biochemistry and Pharmaceutical Sciences, Freiestrasse 3, University of Bern, 3012 Bern, Switzerland.
ORCID-Profile: Simon D Schwarz, Kapila Gunasekera, Michael O Hottiger, Primo Schär
Förderung
- National Network of Advanced Proteomics Infrastructure
- Research Council of Norway
- Mäxi-Foundation
- Swiss Cancer Research Foundation
- Swiss National Science Foundation
Zitieren
APA
Xu, J., Schwarz, S. D., Gunasekera, K., Steinacher, R., Kuśnierczyk, A., Hottiger, M. O., & Schär, P. (2026). PARP1 inhibition in naïve mouse embryonic stem cells induces viral mimicry. Nucleic Acids Research, 54(10). https://doi.org/10.1093/nar/gkag537
Vancouver
Xu J, Schwarz SD, Gunasekera K, Steinacher R, Kuśnierczyk A, Hottiger MO, et al. PARP1 inhibition in naïve mouse embryonic stem cells induces viral mimicry. Nucleic Acids Research. 2026;54(10). doi:10.1093/nar/gkag537
BibTeX
@article{Xu2026,
author = {Xu, Jianming and Schwarz, Simon D and Gunasekera, Kapila and Steinacher, Roland and Kuśnierczyk, Anna and Hottiger, Michael O and Schär, Primo},
title = {PARP1 inhibition in naïve mouse embryonic stem cells induces viral mimicry},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {10},
doi = {10.1093/nar/gkag537}
}
EUVIMED